GILD NEWS! 66.03 Gilead Sciences (GILD)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gilead Sciences (GILD) 66.03 $GILD

Obamacare Enrollment: Quantity OK, Quality Questionable?
Keith Speights, The Motley Fool - Motley Fool - Sun Apr 13, 12:00PM CDT
Quantity versus quality? The age-old question appears to have raised its head again with the latest information about enrollment in the Affordable Care Act, commonly referred to as Obamacare. According to the White House, over 7.5 million Americans...

Biotech Is Officially in a Bear Market. Is It Time to Panic?
Sean Williams, The Motley Fool - Motley Fool - Sat Apr 12, 3:03PM CDT
There was once a time when the biotech sector could do no wrong. Venture capital was literally coming up out of the floor to invest in the latest new development platforms. Secondary offerings were also being met with plenty of buyers. And let's not...

Final Data from the Phase 2 COSMOS Study of Janssen's Once-Daily Simeprevir in Combination with Sofosbuvir Presented at the International Liver Congress(TM) 2014 of the European Association for the Study of the Liver (EASL)
Business Wire - Sat Apr 12, 10:24AM CDT
Janssen R&D Ireland (Janssen) today announced positive new data from the clinical development programme of simeprevir, including final data from cohort 2 of the Phase 2 COSMOS study of the protease inhibitor simeprevir administered once daily with Gilead Sciences Inc.'s nucleotide inhibitor sofosbuvir, with and without ribavirin (RBV), in adult patients chronically infected with genotype 1 hepatitis C virus (HCV). The final data, along with an additional analysis from COSMOS cohort 1 and new subgroup analyses of Phase 3 data in European and genotype 4 HCV patients, were presented at The International Liver Congress(TM) 2014 of the European Association for the Study of the Liver (EASL) in London.

The Hepatitis C Cure Poised to "Break the Country"
Michael Douglass and David Williamson, The Motley Fool - Motley Fool - Sat Apr 12, 7:05AM CDT
Gilead 's Sovaldi is reportedly flying off the shelves, but bad press due to pushback from payers, members of Congress, and even the WHO continues to roll in. At issue is the high price of Sovaldi in the U.S. -- $84,000 for a full course of...

Most active Nasdaq-traded stocks
AP - Fri Apr 11, 5:03PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:

Final Glance: Biotechnology companies
AP - Fri Apr 11, 5:03PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:

Encouraging Results on Gilead's Sovaldi - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 4:15PM CDT
Gilead announced encouraging results from two phase II studies and a compassionate access study on Sovaldi.

JPMorgan's Earnings Disaster Drops the Dow 100 Points
Dan Carroll, The Motley Fool - Motley Fool - Fri Apr 11, 1:38PM CDT
Earnings season has swung around hard on the market today, as the Dow Jones Industrial Average  tumbled 130 points as of 2:30 p.m. EDT following some ugly numbers  from one of America's top big banks. All but a handful of blue-chip stocks are in...

Why Gilead Sciences (GILD) Stock Is Up Today
at The Street - Fri Apr 11, 12:58PM CDT
Gilead Sciences (GILD) shares are up 3.9% to $67.98 in trading on Friday following Texas health board reconsideration

Midday Glance: Biotechnology companies
AP - Fri Apr 11, 12:51PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.:

Drying Stimulus Tap Is Sore Spot for Tech Stocks
at The Street - Fri Apr 11, 12:50PM CDT
The drying stimulus tap rather than stretched valuations has been the trigger for recent selling in tech and biotech shares, some managers argue, claiming this makes another tech sector crash unlikely.

Encouraging Data from Bristol-Myers - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 10:30AM CDT
Bristol-Myers announced positive data on its HCV cocktail treatment from a late stage study.

Jim Cramer's Mad Dash: HRB GILD
at The Street - Fri Apr 11, 9:38AM CDT
The tax man cometh and shows no sign of leaving, which means good news for H&R Block as it spins off its banking division, Cramer says.

Priority Reviews, Preliminary Earnings Releases, Clinical Trials Results, and Launch of Website - Analyst Notes on Gilead, Pfizer, Intuitive Surgical, Alkermes and Quest
PR Newswire - Fri Apr 11, 9:14AM CDT
Today, Analysts Review released its analysts' notes regarding Gilead Sciences Inc. (NASDAQ: GILD), Pfizer Inc. (NYSE: PFE), Intuitive Surgical, Inc. (NASDAQ: ISRG), Alkermes plc (NASDAQ: ALKS) and Quest Diagnostics Inc. (NYSE: DGX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/989-100free.

Stock Market News for April 11, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 9:06AM CDT
Benchmarks ended in the red zone yesterday, once again dragged down by declines in momentum and bio-tech stocks

Merck Shouts "Me, Too!" But Will It Matter?
Todd Campbell, The Motley Fool - Motley Fool - Fri Apr 11, 8:30AM CDT
Merck  has rolled out impressive phase 2 data that shows that it too has a very compelling hepatitis C regimen that may eliminate the use of side-effect laden Peginterferon and ribavirin -- the standard of care just a few short years ago. But...

Gilead Sciences (GILD) Falls: Stock Goes Down 7.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 8:00AM CDT
Gilead Sciences saw a big move last session, as the company’s shares fell by over 7% on the day.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 28

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 204

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 310

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 286

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 398

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 231

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 181

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 273

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 232

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 275

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading

Top 5 Most Recently Viewed Articles

Analyzing Market Sentiment for Amazon.com Inc: Bullish or Bearish?

Updated Category News Views 177

Market Sentiment for Amazon.com Inc Amazon.com Inc (NYSE: AMZN) has recently seen a notable increase in its short interest, rising by 3.95%. This statistic means that there are currently 76.07 million shares sold short, equivalent to 0.79% of all available regular trading shares. Given the current trading volume, it is estimated that traders would need approximately 2.05...

Continue Reading
Venus Qurbanzadeh Takes Ownership of AIM Mail Center

Updated Category News Views 121

New Era for AIM Mail Center with Venus Qurbanzadeh Annex Brands, Inc. is thrilled to announce a pivotal change in ownership at an established AIM Mail Center, now under the leadership of Venus Qurbanzadeh. This transition is a part of the ongoing commitment to provide essential shipping and office services that the community has relied on for 36 years. Expanding Services...

Continue Reading
EnerPure's Innovative Recycling Efforts Significantly Reduce GHGs

Updated Category News Views 205

Understanding EnerPure's Environmental Benefits Report EnerPure Inc., a recycling and energy transition company, has made significant strides in its efforts to curb greenhouse gas (GHG) emissions. The company recently completed an Environmental Benefits Report (EBR) that highlights compelling improvements in its operations. This report has quantified an impressive...

Continue Reading
Masco Corporation Adjusts Financial Outlook Amid Market Changes

Updated Category News Views 108

RBC Capital Markets Downgrades Masco Corporation Stock Recently, RBC Capital Markets made a notable shift in its analysis of Masco Corporation (NYSE: MAS), downgrading its stance from Outperform to Sector Perform. This reassessment comes with a slight increase in the price target for the stock, rising to $80 from $79. The adjustment reflects a balanced perspective on the...

Continue Reading
VinFast Leads the Charge: Accessible Electric SUVs for Canada

Updated Category News Views 260

Growing Trends in Canadian Car Buying Markham, Ontario — Canadians are undergoing a significant transformation in their car-buying preferences, driven primarily by economic pressures that necessitate a focus on practicality and affordability. As traditional luxury vehicles lose their allure, more consumers are gravitating towards options that prioritize reliability,...

Continue Reading